Rallybio CorporationRLYBNASDAQ
LOADING
|||
Operating Income Contraction
Trending higher, below historical average, strong compound growth.
Left:
|
|
|
|

Profit from core business operations before interest and taxes

Latest
$-60.50M
↓ 23% below average
Average (5y)
$-49.32M
Historical baseline
Range
High:$-17.64M
Low:$-78.93M
CAGR
+27.9%
Consistent expansion
PeriodValueChange
2024$-60.50M+23.4%
2023$-78.93M-16.3%
2022$-67.88M-48.7%
2021$-45.65M-80.4%
2020$-25.30M-43.4%
2019$-17.64M-